First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer
Niu, J., Maurice-Dror, C., Lee, D.H., Kim, D.-W., Nagrial, A., Voskoboynik, M., Chung, H.C., Mileham, K., Vaishampayan, U., Rasco, D., Golan, T., Bauer, T.M., Jimeno, A., Chung, V., Chartash, E., Lala, M., Chen, Q., Healy, J.A., Ahn, M.-J.
Published in Annals of oncology (01.02.2022)
Published in Annals of oncology (01.02.2022)
Get full text
Journal Article
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
Herbst, R.S., Baas, P., Perez-Gracia, J.L., Felip, E., Kim, D.-W., Han, J.-Y., Molina, J.R., Kim, J.-H., Dubos Arvis, C., Ahn, M.-J., Majem, M., Fidler, M.J., Surmont, V., de Castro, G., Garrido, M., Shentu, Y., Emancipator, K., Samkari, A., Jensen, E.H., Lubiniecki, G.M., Garon, E.B.
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials
Goss, G., Tsai, C.-M., Shepherd, F.A., Ahn, M.-J., Bazhenova, L., Crinò, L., de Marinis, F., Felip, E., Morabito, A., Hodge, R., Cantarini, M., Johnson, M., Mitsudomi, T., Jänne, P.A., Yang, J.C.-H.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
Oxnard, G.R., Yang, J.C.-H., Yu, H., Kim, S.-W., Saka, H., Horn, L., Goto, K., Ohe, Y., Mann, H., Thress, K.S., Frigault, M.M., Vishwanathan, K., Ghiorghiu, D., Ramalingam, S.S., Ahn, M.-J.
Published in Annals of oncology (01.04.2020)
Published in Annals of oncology (01.04.2020)
Get full text
Journal Article
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, Tony S, Wu, Yi-Long, Ahn, Myung-Ju, Garassino, Marina C, Kim, Hye R, Ramalingam, Suresh S, Shepherd, Frances A, He, Yong, Akamatsu, Hiroaki, Theelen, Willemijn S.M.E, Lee, Chee K, Sebastian, Martin, Templeton, Alison, Mann, Helen, Marotti, Marcelo, Ghiorghiu, Serban, Papadimitrakopoulou, Vassiliki A
Published in The New England journal of medicine (16.02.2017)
Published in The New England journal of medicine (16.02.2017)
Get full text
Journal Article
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
Lim, S.H, Hong, M, Ahn, S, Choi, Y.-L, Kim, K.-M, Oh, D, Ahn, Y.C, Jung, S.-H, Ahn, M.-J, Park, K, Zo, J.I, Shim, Y.M, Sun, J.-M
Published in European journal of cancer (1990) (01.01.2016)
Published in European journal of cancer (1990) (01.01.2016)
Get full text
Journal Article
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study
Psyrri, A., Fayette, J., Harrington, K., Gillison, M., Ahn, M.-J., Takahashi, S., Weiss, J., Machiels, J.-P., Baxi, S., Vasilyev, A., Karpenko, A., Dvorkin, M., Hsieh, C.-Y., Thungappa, S.C., Segura, P.P., Vynnychenko, I., Haddad, R., Kasper, S., Mauz, P.-S., Baker, V., He, P., Evans, B., Wildsmith, S., Olsson, R.F., Yovine, A., Kurland, J.F., Morsli, N., Seiwert, T.Y.
Published in Annals of oncology (01.03.2023)
Published in Annals of oncology (01.03.2023)
Get full text
Journal Article
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)
Blumenschein, G.R., Smit, E.F., Planchard, D., Kim, D.-W., Cadranel, J., De Pas, T., Dunphy, F., Udud, K., Ahn, M.-J., Hanna, N.H., Kim, J.-H., Mazieres, J., Kim, S.-W., Baas, P., Rappold, E., Redhu, S., Puski, A., Wu, F.S., Jänne, P.A.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
Lee, S.-H., Lee, J.-K., Ahn, M.-J., Kim, D.-W., Sun, J.-M., Keam, B., Kim, T.M., Heo, D.S., Ahn, J.S., Choi, Y.-L., Min, H.-S., Jeon, Y.K., Park, K.
Published in Annals of oncology (01.02.2017)
Published in Annals of oncology (01.02.2017)
Get full text
Journal Article
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
Shim, J.H., Kim, H.S., Cha, H., Kim, S., Kim, T.M., Anagnostou, V., Choi, Y.-L., Jung, H.A., Sun, J.-M., Ahn, J.S., Ahn, M.-J., Park, K., Park, W.-Y., Lee, S.-H.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
Papadimitrakopoulou, V.A., Mok, T.S., Han, J.-Y., Ahn, M.-J., Delmonte, A., Ramalingam, S.S., Kim, S.W., Shepherd, F.A., Laskin, J., He, Y., Akamatsu, H., Theelen, W.S.M.E., Su, W.-C., John, T., Sebastian, M., Mann, H., Miranda, M., Laus, G., Rukazenkov, Y., Wu, Y.-L.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
Reexamining the Nonlinear Moisture‐Precipitation Relationship Over the Tropical Oceans
Rushley, S. S., Kim, D., Bretherton, C. S., Ahn, M.‐S.
Published in Geophysical research letters (28.01.2018)
Published in Geophysical research letters (28.01.2018)
Get full text
Journal Article
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy
Park, S., Lee, M.-H., Seong, M., Kim, S.T., Kang, J.-H., Cho, B.C., Lee, K.H., Cho, E.K., Sun, J.-M., Lee, S.-H., Ahn, J.S., Park, K., Ahn, M.-J.
Published in Annals of oncology (01.10.2020)
Published in Annals of oncology (01.10.2020)
Get full text
Journal Article
136O Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial
Ahn, M.-J., Yang, J., Yu, H., Saka, H., Ramalingam, S., Goto, K., Kim, S.-W., Yang, L., Walding, A., Oxnard, G.R.
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial
Hui, R., Garon, E.B., Goldman, J.W., Leighl, N.B., Hellmann, M.D., Patnaik, A., Gandhi, L., Eder, J.P., Ahn, M.-J., Horn, L., Felip, E., Carcereny, E., Rangwala, R., Lubiniecki, G.M., Zhang, J., Emancipator, K., Roach, C., Rizvi, N.A.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
Chan, A.T.C., Lee, V.H.F., Hong, R.-L., Ahn, M.-J., Chong, W.Q., Kim, S.-B., Ho, G.F., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Aziz, M.A.S.A., Ng, Q.S., Yen, C.-J., Soparattanapaisarn, N., Ngan, R.K.-C., Kho, S.K., Tiambeng, M.L.A., Yun, T., Sriuranpong, V., Algazi, A.P., Cheng, A., Massarelli, E., Swaby, R.F., Saraf, S., Yuan, J., Siu, L.L.
Published in Annals of oncology (01.03.2023)
Published in Annals of oncology (01.03.2023)
Get full text
Journal Article
On-chip fabrication of ZnO-nanowire gas sensor with high gas sensitivity
Ahn, M.-W., Park, K.-S., Heo, J.-H., Kim, D.-W., Choi, K.J., Park, J.-G.
Published in Sensors and actuators. B, Chemical (24.04.2009)
Published in Sensors and actuators. B, Chemical (24.04.2009)
Get full text
Journal Article
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial
Guo, Y., Ahn, M.-J., Chan, A., Wang, C.-H., Kang, J.-H., Kim, S.-B., Bello, M., Arora, R.S., Zhang, Q., He, X., Li, P., Dechaphunkul, A., Kumar, V., Kamble, K., Li, W., Kandil, A., Cohen, E.E.W., Geng, Y., Zografos, E., Tang, P.Z.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
Perets, R., Bar, J., Rasco, D.W., Ahn, M.-J., Yoh, K., Kim, D.-W., Nagrial, A., Satouchi, M., Lee, D.H., Spigel, D.R., Kotasek, D., Gutierrez, M., Niu, J., Siddiqi, S., Li, X., Cyrus, J., Chackerian, A., Chain, A., Altura, R.A., Cho, B.C.
Published in Annals of oncology (01.03.2021)
Published in Annals of oncology (01.03.2021)
Get full text
Journal Article